Skip to main content
Atrás
Watch Compare

Passage BIO, Inc.

Calidad de datos: 83%
PASG
Nasdaq Manufacturing Chemicals
$11.14
▲ $1.85 (19.91%)
Cap. Mercado: 35.74 M
Precio
$11.14
Cap. Mercado
35.74 M
Rango del Día
$9.26 — $11.19
Rango de 52 Semanas
$5.12 — $20.00
Volumen
108,083
Apertura $9.26
Promedio 50D / 200D
$8.83
26.22% above
Promedio 50D / 200D
$8.56
30.19% above

Quick Summary

Puntos Clave

Negative free cash flow of -31.51 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-131.23%
Below sector avg (-53.47%)
ROIC-69.97%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio2.51
Interest CoverageN/A

Valoración

PE (TTM)
-0.79
Above sector avg (-1.47)
P/B Ratio1.15
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -0.8 -1.5
P/B 1.2 1.6
ROE % -131.2 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

BRSIX BRSIX
0.03% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -45.52 M
ROE -131.23% ROA -59.37%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -31.51 M
ROIC -69.97% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2.51
Interest Coverage N/A Asset Turnover N/A
Working Capital 33.49 M Tangible Book Value 31.12 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.79 Forward P/E N/A
P/B Ratio 1.15 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -88.17%
Market Cap 35.74 M Enterprise Value -17.04 M
Per Share
EPS (Diluted TTM) -14.35 Revenue / Share N/A
FCF / Share -9.82 OCF / Share -9.82
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 69.22%
SBC-Adj. FCF -35.30 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -45.52 M -64.77 M -102.06 M -136.13 M -185.39 M
EPS (Diluted) -14.35 -1.07 -1.86 -2.50 -3.48
Gross Profit — — — — —
Operating Income -49.30 M -70.40 M -108.39 M -138.39 M -185.73 M
EBITDA — — — — —
R&D Expenses 23.28 M 40.18 M — — —
SG&A Expenses — — — — —
D&A 728,000.0 3.08 M 3.72 M 3.68 M 1.54 M
Interest Expense — — — — —
Income Tax 0.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 62.28 M 102.41 M 150.55 M 243.55 M 355.08 M
Total Liabilities 43.53 M 41.15 M 39.26 M 42.18 M 36.42 M
Shareholders' Equity 18.76 M 61.26 M 111.28 M 201.37 M 318.66 M
Total Debt — — — — —
Cash & Equivalents 46.30 M 37.57 M 21.71 M 34.60 M 128.97 M
Current Assets 47.76 M 78.82 M 117.96 M 197.04 M 325.07 M
Current Liabilities 23.08 M 19.36 M 16.34 M 18.35 M 29.50 M